Top 10 at 10: Gold discoveries, M&A, and a $50m payday
Stockhead’s Top 10 at 10, published at ~10.40am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. [more…]
Adavale Resources embarks on uranium hunt in South Australia
Adavale Resources to start uranium exploration on its Mundowdna and Mundowdna South licences Exploration program includes gravity and gamma spectrometer surveying, soil and rock chip [more…]
Pure Hydrogen’s green hydrogen micro-hub strategy is taking off
Pure Hydrogen leases Archerfield airport industrial site for first demonstration green hydrogen micro-hub Electrolyser already ordered and first hydrogen production is expected in Q4 2024 [more…]
Market Highlights: Rout on Wall Street as gold, Fear Index spike sharply higher; and 5 small caps to watch
ASX to track Wall Street and drop sharply today This comes as US retail sales date came in much stronger than expected Gold price [more…]
Lycaon on the road to drill Stansmore niobium-rare earths project in red hot West Arunta
Lycaon Resources has received a key land access permit for drilling at its Stansmore project in WA’s West Arunta region Project is close to WA1’s [more…]
The secret recipe that could make Impact Minerals HPA’s Michelin Star chef
Impact Minerals is aiming to become a disruptive player in the high purity alumina market Boss Dr Mike Jones thinks the company could produce the [more…]
Rise and Shine: Everything you need to know before the ASX opens
Good morning everyone, today on Stockhead, Nadine’s very interested in old drugs making a comeback, Eddy’s got a couple of broker upgrades, and Jess [more…]
Which ASX companies are resurrecting abandoned drugs? Part 1
Even after showing effectiveness in late-stage trials, as many potential treatments fail to reach the market There are several reasons for drugs not making it [more…]
Here’s why lower smelter prices spells opportunity for ASX zinc explorers
Zinc prices have been in the doldrums in recent times but the tide is changing with lower smelter prices signalling a market shortfall Analysts say [more…]
MoneyTalks: Pointsbet exits US business, will gain market share in Australia says broker
Clarity Pharma rated Overweight by Wilsons on near term catalysts Pointsbet has exited US and will now focus on the Aussie market Jarden says Pointsbet [more…]
